Related Experiment Video
Updated: Jul 18, 2026

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
Published on: February 24, 2014
Effect of p53 haploinsufficiency on melphalan-induced genotoxic effects in mouse bone marrow and peripheral blood
R Ranaldi1, S Palma, C Tanzarella
1Section of Toxicology and Biomedical Sciences, ENEA, CR Casaccia, Via Anguillarese 301, 00060 Roma, Italy.
Abstract:
Mice heterozygous for a p53 null mutation develop tumours induced by genotoxic carcinogens with a shorter latency than wild type mice and have been proposed as an alternate animal model for carcinogenicity testing. Some literature data suggest that p53+/- mice might also be more sensitive to the short-term effects of genotoxic agents and manifest a haploinsufficiency phenotype that could contribute to the higher tumour susceptibility. We have compared the induction of micronuclei in bone marrow and blood of p53+/- and p53+/+ isogenic mice after treatment with a single or multiple doses of melphalan (MLP), a crosslinking genotoxic carcinogen. We have also characterized the mechanism of micronucleus induction with CREST staining of kinetochore proteins to distinguish between chromosome break- and chromosome loss-induced micronuclei. Significant increases of micronucleated bone marrow polychromatic erythrocytes and blood reticulocytes were induced under all MLP exposure conditions. The frequency of micronucleated blood erythrocytes increased linearly with duration of exposure. Micronuclei were essentially a consequence of chromosome break events. After a single MLP dose, a significant reduction of the frequency of polychromatic erythrocytes in bone marrow of p53+/+ animals suggested the induction of cytotoxicity/cell cycle delay. This effect was not observed in p53+/- mice. We believe this finding to provide some evidence of a haploinsufficiency phenotype in the modulation of cell cycle/apoptotic pathways mediated by the p53 protein. In bone marrow of wild type mice, an increased effect of multiple MLP doses was detected over that of a single administration, whereas, in p53+/- mice, no differential effect was found of different exposure durations. Possibly, the probability of micronucleus formation increased under chronic exposure because of increased cell division in response to peripheral anemia and a reduction of p53 protein level had a small effect on cell cycle modulation and on such indirect mechanism of micronucleus induction. However, pairwise comparisons between the frequencies of cells with micronuclei in wild type and p53+/- mice under all exposure conditions did not show statistically significant differences, suggesting that the observed effects of p53 haploinsufficiency were weak and temporary and a higher/faster induction of irreversible chromosome damage could not account for the increased susceptibility of p53+/- mice to MLP-induced tumours.
Insights
Mice with one functional p53 gene (p53+/-) showed weak, temporary differences in DNA damage response compared to normal mice (p53+/+) after melphalan exposure. This suggests p53 haploinsufficiency has a limited impact on genotoxicity testing models.
Area of Science:
- Toxicology and Carcinogenesis
- Genetics and Molecular Biology
- Animal Models in Research
Background:
- Mice heterozygous for a p53 null mutation (p53+/-) are proposed as an alternative model for carcinogenicity testing due to shorter tumor latency.
- Literature suggests p53+/- mice may exhibit increased sensitivity to genotoxic agents and a haploinsufficiency phenotype contributing to tumor susceptibility.
Purpose of the Study:
- To compare the induction of micronuclei in p53+/- and p53+/+ mice after melphalan (MLP) treatment.
- To characterize the mechanism of MLP-induced micronucleus formation (chromosome break vs. loss).
- To investigate evidence of p53 haploinsufficiency in cell cycle modulation and apoptotic pathways.
Main Methods:
- Treatment of isogenic p53+/- and p53+/+ mice with single or multiple doses of melphalan (MLP).
- Analysis of micronuclei induction in bone marrow polychromatic erythrocytes and peripheral blood reticulocytes.
- CREST staining of kinetochore proteins to differentiate between chromosome break and loss events.
- Assessment of cytotoxicity and cell cycle delay via polychromatic erythrocyte frequency.
Main Results:
- MLP induced significant increases in micronucleated cells in both mouse genotypes under all exposure conditions.
- Micronuclei were primarily a result of chromosome breaks.
- p53+/+ mice showed cytotoxicity/cell cycle delay after a single MLP dose, an effect absent in p53+/- mice, suggesting p53 haploinsufficiency.
- No statistically significant differences in micronuclei frequency were observed between p53+/- and p53+/+ mice, indicating weak and temporary effects of p53 haploinsufficiency.
Conclusions:
- p53 haploinsufficiency in p53+/- mice appears to have weak and temporary effects on cell cycle modulation and DNA damage response to melphalan.
- The increased susceptibility of p53+/- mice to MLP-induced tumors cannot be solely attributed to a higher or faster induction of irreversible chromosome damage.
- Further research is needed to fully elucidate the role of p53 haploinsufficiency in carcinogenicity testing models.

